Understanding how APOE4 affects brain cell function in Alzheimer's disease

Elucidating endolysosomal trafficking dysregulation induced by APOE4 in human astrocytes

NIH-funded research Boston University Medical Campus · NIH-11078325

This study is looking at how a specific gene called APOE4 might affect brain cells and contribute to Alzheimer's disease, with the goal of finding new ways to help treat the condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University Medical Campus NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11078325 on NIH RePORTER

What this research studies

This research investigates the role of the APOE4 gene variant in the development of Alzheimer's disease by examining how it disrupts the normal trafficking of cellular components in brain cells, particularly astrocytes. The study utilizes advanced techniques to analyze human brain cell types derived from induced pluripotent stem cells, focusing on how APOE4 influences cholesterol metabolism and other cellular processes. By identifying the specific mechanisms involved, the research aims to uncover potential therapeutic targets for Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a genetic predisposition to Alzheimer's disease, particularly those who are carriers of the APOE4 allele.

Not a fit: Patients without the APOE4 allele or those with other forms of dementia unrelated to Alzheimer's may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that better manage or even prevent Alzheimer's disease in individuals carrying the APOE4 variant.

How similar studies have performed: Previous research has shown promising results in understanding the role of genetic variants in Alzheimer's disease, making this approach both relevant and potentially impactful.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease brain
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.